Trial
NCT01417104
Aliskiren Effect on Aortic Plaque Progression
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Ohio State University
Collaborators
Novartis
Condition
Atherosclerosis
Intervention
Aliskiren
Why stopped
Safety concerns with approved medication identified in an unrelated trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-11